We will be tracking these developments closely in the coming months.
No Significant Increase in Heart Failure Risk: Concerns regarding an increase in heart failure with saxagliptin, and to a lesser extent alogliptin, resulted in no use or cautious use of these agents in patients with cardiac backgrounds
But over the past 15 years, dark spots started to form on my face, my hands, my arms and especially on my legs
As the GLP-1 market continues to grow, pharmaceutical companies must adapt their clinical trial approaches to maintain competitiveness
In musculoskeletal injury models, this dual actionvascularization of the injured site + cell recruitment + reduction of fibrotic scar tissueis being studied for its effects on the speed and quality of repair
Always allow the vial to come to room temperature before mixing to prevent condensation from forming inside